Vimarsana
Biggest News Aggregation in the World

Page 8 - Pharmaceutical Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Development Today - Breaking & Trending Today

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT - Vimarsana News

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group. With this strategic alliance, PLG, a global provider of regulatory

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT - Vimarsana News

PRODUCTLIFE GROUP ANNOUNCES ITS INTENTION TO MERGE WITH PHARMA D&S GROUP, EXPANDING ITS OVERALL OFFERING AND ITALIAN FOOTPRINT

ProductLife Group is reaching a key step in its growth with the acquisition of privately owned Italian company Pharma D&S Group. With this strategic alliance, PLG, a global provider of regulatory

SWK (NASDAQ:SWKH) Shares Down 1.5% - Vimarsana News

SWK (NASDAQ:SWKH) Shares Down 1.5%

SWK Holdings Co. (NASDAQ:SWKH – Get Rating)’s stock price fell 1.5% during trading on Wednesday . The company traded as low as $16.47 and last traded at $16.85. 110,369 shares traded hands during mid-day trading, an increase of 834% from the average session volume of 11,814 shares. The stock had previously closed at $17.10. Analyst […]

Lundbeck and Otsuka announce U.S. Food and Drug Administration (FDA) approval of sNDA for Rexulti® (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer's Disease - Vimarsana News

Lundbeck and Otsuka announce U.S. Food and Drug Administration (FDA) approval of sNDA for Rexulti® (brexpiprazole) for the treatment of agitation associated with dementia due to Alzheimer's Disease

Rexulti is the first and only pharmacological treatment approved in the U.S. for agitation associated with dementia due to Alzheimer's disease Valby, Denmark, May 11, 2023 - H. Lundbeck A/S and... | May 11, 2023

SWK Holdings Corporation Announces Financial Results for First Quarter 2023 - Vimarsana News

SWK Holdings Corporation Announces Financial Results for First Quarter 2023

Conference Call and Live Audio Webcast Scheduled for Thursday, May 11, 2023, at 10:00 a.m. ET Corporate Highlights First quarter 2023 GAAP net income was $4.6...